Sorenson John Bradley's Form 4 filing
Boston Scientific Corp (BSX) · filed Feb 18, 2025
- Accession no.
- 0001225208-25-001878
- Filed
- Feb 18, 2025
- Trade date
- Feb 13-17, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 5 derivative transactions. Open-market sales total $127.7K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sorenson John BradleyCIK 0001629277 | Officer (EVP, Global Operations) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | Common Stock | MOption exerciseAcquired | +2,115 | $0.00F1 | $0 | 27,609 | Direct | |
| Feb 14, 2025 | Common Stock | FTax withholdingDisposed | −965 | $106.11 | −$102,396.15 | 26,644 | Direct | |
| Feb 14, 2025 | Common Stock | SSaleDisposed | −1,201 | $106.31 | −$127,678.31 | 25,443 | Direct | |
| Feb 16, 2025 | Common Stock | MOption exerciseAcquired | +1,273 | $0.00F1 | $0 | 26,716 | Direct | |
| Feb 16, 2025 | Common Stock | FTax withholdingDisposed | −581 | $106.11 | −$61,649.91 | 26,135 | Direct | |
| Feb 17, 2025 | Common Stock | MOption exerciseAcquired | +1,500 | $0.00F1 | $0 | 27,635 | Direct | |
| Feb 17, 2025 | Common Stock | FTax withholdingDisposed | −684 | $106.11 | −$72,579.24 | 26,951 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | Common Stock | AGrant or awardAcquired | +4,239 | $0.00 | $0 | 4,239 | Direct | |
| Feb 13, 2025 | Common Stock | AGrant or awardAcquired | +10,909 | $0.00 | $0 | 10,909 | Direct | |
| Feb 14, 2025 | Common Stock | MOption exerciseDisposed | −2,115 | $0.00 | $0 | 4,230 | Direct | |
| Feb 16, 2025 | Common Stock | MOption exerciseDisposed | −1,273 | $0.00 | $0 | 1,273 | Direct | |
| Feb 17, 2025 | Common Stock | MOption exerciseDisposed | −1,500 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Referenced by the price of 3 transactions in Table I.